HK1257042A1 - 用於tau成像的氮雜環丁烷衍生物 - Google Patents
用於tau成像的氮雜環丁烷衍生物Info
- Publication number
- HK1257042A1 HK1257042A1 HK18116177.1A HK18116177A HK1257042A1 HK 1257042 A1 HK1257042 A1 HK 1257042A1 HK 18116177 A HK18116177 A HK 18116177A HK 1257042 A1 HK1257042 A1 HK 1257042A1
- Authority
- HK
- Hong Kong
- Prior art keywords
- azetidine derivatives
- tau imaging
- tau
- imaging
- azetidine
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
- A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
- A61K51/04—Organic compounds
- A61K51/041—Heterocyclic compounds
- A61K51/044—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins
- A61K51/0444—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins having four-membered rings, e.g. azetidine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
- A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
- A61K51/04—Organic compounds
- A61K51/041—Heterocyclic compounds
- A61K51/044—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins
- A61K51/0453—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
- A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
- A61K51/04—Organic compounds
- A61K51/041—Heterocyclic compounds
- A61K51/044—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins
- A61K51/0455—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
- C07B59/00—Introduction of isotopes of elements into organic compounds ; Labelled organic compounds per se
- C07B59/002—Heterocyclic compounds
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
- C07B2200/00—Indexing scheme relating to specific properties of organic compounds
- C07B2200/05—Isotopically modified compounds, e.g. labelled
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Physics & Mathematics (AREA)
- Epidemiology (AREA)
- Optics & Photonics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Neurosurgery (AREA)
- Engineering & Computer Science (AREA)
- Neurology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biomedical Technology (AREA)
- Hospice & Palliative Care (AREA)
- Psychiatry (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Plural Heterocyclic Compounds (AREA)
- Peptides Or Proteins (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201562254906P | 2015-11-13 | 2015-11-13 | |
| PCT/US2016/060621 WO2017083198A1 (en) | 2015-11-13 | 2016-11-04 | Azetidine derivatives for tau imaging |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| HK1257042A1 true HK1257042A1 (zh) | 2019-10-11 |
Family
ID=57389526
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| HK18116177.1A HK1257042A1 (zh) | 2015-11-13 | 2018-12-18 | 用於tau成像的氮雜環丁烷衍生物 |
Country Status (19)
| Country | Link |
|---|---|
| US (1) | US10301308B2 (zh) |
| EP (1) | EP3374358B1 (zh) |
| JP (1) | JP2018531978A (zh) |
| KR (1) | KR20180061364A (zh) |
| CN (1) | CN108290883B (zh) |
| AU (1) | AU2016351609B2 (zh) |
| BR (1) | BR112018006969B1 (zh) |
| CA (1) | CA3003884C (zh) |
| DK (1) | DK3374358T3 (zh) |
| EA (1) | EA034018B1 (zh) |
| ES (1) | ES2864825T3 (zh) |
| HK (1) | HK1257042A1 (zh) |
| IL (1) | IL258313B (zh) |
| MX (1) | MX2018005376A (zh) |
| PL (1) | PL3374358T3 (zh) |
| PT (1) | PT3374358T (zh) |
| SA (1) | SA518391527B1 (zh) |
| WO (1) | WO2017083198A1 (zh) |
| ZA (1) | ZA201802526B (zh) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU2023216231A1 (en) * | 2022-02-03 | 2024-08-01 | Eli Lilly And Company | Regional tau imaging for diagnosing and treating alzheimer's disease |
| WO2024163546A1 (en) * | 2023-02-02 | 2024-08-08 | Eli Lilly And Company | Novel compounds for tau imaging |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7118730B2 (en) * | 2002-12-16 | 2006-10-10 | Bf Research Institute, Inc. | Quinoline derivative as diagnostic probe for disease with tau protein accumulation |
| DK2247558T4 (da) | 2008-02-14 | 2024-07-29 | Lilly Co Eli | Nye billeddannelsesmidler til detektering af neurologisk dysfunktion |
| DK2381967T3 (en) * | 2008-12-31 | 2017-03-27 | Avid Radiopharmaceuticals Inc | Synthesis of 18F-radiolabelled styryl pyridines from tosylate precursors and stable pharmaceutical compositions thereof |
| US8691187B2 (en) * | 2009-03-23 | 2014-04-08 | Eli Lilly And Company | Imaging agents for detecting neurological disorders |
| ES2792830T3 (es) | 2012-05-22 | 2020-11-12 | Lilly Co Eli | Agentes para formación de imagen en base a carbolina y carbazol, para la detección de disfunción neurológica |
-
2016
- 2016-11-04 KR KR1020187013117A patent/KR20180061364A/ko not_active Application Discontinuation
- 2016-11-04 US US15/763,608 patent/US10301308B2/en active Active
- 2016-11-04 PT PT167988740T patent/PT3374358T/pt unknown
- 2016-11-04 WO PCT/US2016/060621 patent/WO2017083198A1/en active Application Filing
- 2016-11-04 AU AU2016351609A patent/AU2016351609B2/en active Active
- 2016-11-04 BR BR112018006969-8A patent/BR112018006969B1/pt active IP Right Grant
- 2016-11-04 EP EP16798874.0A patent/EP3374358B1/en active Active
- 2016-11-04 DK DK16798874.0T patent/DK3374358T3/da active
- 2016-11-04 JP JP2018522120A patent/JP2018531978A/ja not_active Withdrawn
- 2016-11-04 CN CN201680066210.8A patent/CN108290883B/zh active Active
- 2016-11-04 ES ES16798874T patent/ES2864825T3/es active Active
- 2016-11-04 EA EA201890799A patent/EA034018B1/ru not_active IP Right Cessation
- 2016-11-04 PL PL16798874T patent/PL3374358T3/pl unknown
- 2016-11-04 MX MX2018005376A patent/MX2018005376A/es unknown
- 2016-11-04 CA CA3003884A patent/CA3003884C/en active Active
-
2018
- 2018-03-22 IL IL258313A patent/IL258313B/en active IP Right Grant
- 2018-04-17 ZA ZA201802526A patent/ZA201802526B/en unknown
- 2018-05-07 SA SA518391527A patent/SA518391527B1/ar unknown
- 2018-12-18 HK HK18116177.1A patent/HK1257042A1/zh unknown
Also Published As
| Publication number | Publication date |
|---|---|
| PL3374358T3 (pl) | 2021-07-12 |
| MX2018005376A (es) | 2018-08-01 |
| CN108290883A (zh) | 2018-07-17 |
| EP3374358B1 (en) | 2021-02-17 |
| BR112018006969B1 (pt) | 2022-04-26 |
| BR112018006969A2 (pt) | 2018-10-16 |
| SA518391527B1 (ar) | 2021-02-07 |
| KR20180061364A (ko) | 2018-06-07 |
| JP2018531978A (ja) | 2018-11-01 |
| IL258313A (en) | 2018-05-31 |
| CA3003884C (en) | 2020-04-21 |
| ZA201802526B (en) | 2019-10-30 |
| EA034018B1 (ru) | 2019-12-19 |
| US20180282322A1 (en) | 2018-10-04 |
| IL258313B (en) | 2021-04-29 |
| US10301308B2 (en) | 2019-05-28 |
| EA201890799A1 (ru) | 2018-10-31 |
| CA3003884A1 (en) | 2017-05-18 |
| CN108290883B (zh) | 2021-02-09 |
| PT3374358T (pt) | 2021-03-31 |
| WO2017083198A1 (en) | 2017-05-18 |
| DK3374358T3 (da) | 2021-03-08 |
| EP3374358A1 (en) | 2018-09-19 |
| AU2016351609A1 (en) | 2018-04-19 |
| AU2016351609B2 (en) | 2019-08-08 |
| ES2864825T3 (es) | 2021-10-14 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DK3478217T3 (en) | Historisk scanningsreference for intraorale scanninger | |
| IL258213A (en) | Pharmaceutical compounds | |
| GB201506658D0 (en) | Pharmaceutical compounds | |
| IL258246A (en) | Pharmaceutical compounds | |
| GB201504675D0 (en) | Pharmaceutical compounds | |
| EP3322178A4 (en) | Imaging device | |
| GB201519352D0 (en) | Pharmaceutical compounds | |
| GB201506660D0 (en) | Pharmaceutical compounds | |
| HUE048051T2 (hu) | Képalkotó egységek | |
| EP3321964A4 (en) | Imaging device | |
| EP3250716A4 (en) | Microscope-free imaging | |
| EP3396937A4 (en) | IMAGING DEVICE | |
| EP3280133A4 (en) | Imaging device | |
| EP3343912A4 (en) | IMAGING DEVICE | |
| GB201506933D0 (en) | Pharmaceutical compounds | |
| EP3392707A4 (en) | IMAGE FORMING DEVICE | |
| GB201502567D0 (en) | Pharmaceutical compounds | |
| EP3258312A4 (en) | Imaging device | |
| EP3333627A4 (en) | IMAGING DEVICE | |
| HK1220537A1 (zh) | 種單分子圖像糾偏裝置 | |
| EP3288250A4 (en) | Imaging device | |
| HK1257042A1 (zh) | 用於tau成像的氮雜環丁烷衍生物 | |
| EP3352445A4 (en) | Imaging device | |
| EP3285480A4 (en) | Imaging device | |
| EP3188470A4 (en) | Imaging apparatus |